1. Home
  2. BRFH vs LPCN Comparison

BRFH vs LPCN Comparison

Compare BRFH & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barfresh Food Group Inc.

BRFH

Barfresh Food Group Inc.

N/A

Current Price

$0.79

Market Cap

18.4M

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$1.76

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRFH
LPCN
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.7M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
BRFH
LPCN
Price
$0.79
$1.76
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$4.00
★ $5.00
AVG Volume (30 Days)
31.9K
★ 1.5M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 10.53
N/A
EPS
★ N/A
N/A
Revenue
$211,467.00
★ $1,976,677.00
Revenue This Year
$60.90
N/A
Revenue Next Year
$27.89
$18.02
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 92.09
N/A
52 Week Low
$0.77
$1.81
52 Week High
$3.73
$12.37

Technical Indicators

Market Signals
Indicator
BRFH
LPCN
Relative Strength Index (RSI) 25.01 29.43
Support Level $0.77 N/A
Resistance Level $1.45 $2.30
Average True Range (ATR) 0.11 0.18
MACD -0.00 -0.03
Stochastic Oscillator 3.13 0.01

Price Performance

Historical Comparison
BRFH
LPCN

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: